CV Lattes
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Universidade Federal do Paraná (1994), bachelor's at Monitoria Em Psiquiatria from Universidade Federal do Paraná (1993) and doctorate at Psychiatry from Universidade de São Paulo (2001). Has experience in Medicine, focusing on Psychiatry, acting on the following subjects: bprs, entrevista estruturada, escalas de avaliação em psiquiatria, ansiedade and confiabilidade. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The aim of this work is to conduct a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of cannabidiol (CBD - 300 mg a day) in patients infected with SARS-CoV-2. The specific objectives are to assess whether, in patients with mild and moderate forms of SARS-CoV-2, daily use of CBD 300 mg for fourteen days is capable of: I) decrease viral load; II…
The National Institute of Translational Medicine (NITM) was created in 2008 with the purpose of establishing a national network of research centers with outstanding experience in the investigation of biomarkers and new therapeutic targets and molecules in neuropsychiatric disorders, acting in the strategic area of Health and Medicines defined by the Federal Government. In the base of all …
Agomelatine, a new antidepressant, is a melantonine (MT1 and MT2) and serotonine (5-HT2C) receptor agonist. Clinical and animals studies' results suggest agomelatine may have anxiolytic property; however there is currently only 1 case report with social anxiety disorder (SAD) participant and therefore, agomelatine was never used in randomized, double-blind and placebo controlled study. Un…
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders whose symptoms include impaired communication and social interaction and restricted or repetitive motor movements often associated with cognitive deficits. ASD is observed in early childhood, with a higher prevalence in males. Although it is among the most serious chronic childhood disorders in terms of prevalence, …
Some studies have been performed in search of a better understanding of the role of the endocannabinoid system in the sleep cycle. The aim of this study is to evaluate the effects of administration of cannabidiol in the sleep of healthy volunteers subjected to transient insomnia model, generated by changes in the sleep cycle environment. A sample of 30, selected according to the eligibili…
Agomelatine, a new antidepressant, is a melantonine (MT1 and MT2) and serotonine (5-HT2C) receptor agonist. Clinical and animals studies' results suggest agomelatine may have anxiolytic property; however there is currently only 1 case report with social anxiety disorder (SAD) participant and therefore, agomelatine was never used in randomized, double-blind and placebo controlled study. Un…
Between non-motor symptoms of Parkinson's' disease (PD), anxiety represents an important prevalence in patients with the disease. Though there is no knowledge of its real etiology, it has been observed, clinically and empirically, some correspondence between anxiety symptoms and the typical motor symptoms of PD. This research project aims to validate the simulation test of public speech i…
(Only some records are available in English at this moment)
| 3 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 11 / 4 | Completed scholarships in Brazil |
| 15 / 8 | All research grants and scholarships |
| Associated processes | |